Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020440 (
hypercapnia
)
7,939
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cyclin-dependent kinase-like 5
(
CDKL5
) is an X-linked gene encoding a serine-threonine kinase that is highly expressed in the central nervous system. Mutations in
CDKL5
cause neurological and psychiatric symptoms, including early-onset seizures, motor dysfunction, autistic features and sleep breathing abnormalities in patients. It remains to be addressed whether loss of
CDKL5
causes respiratory dysfunction in mice. Here, we examined the respiratory pattern of male Cdkl5
-/y
mice at 1-3 months of age during resting breathing and respiratory challenge (i.e., hypoxia and
hypercapnia
) via whole body plethysmography. The results demonstrated that the resting respiratory frequency and tidal volume of Cdkl5
-/y
mice was unaltered compared to that of WT mice at 1 month of age. However, these mutant mice exhibit transient reduction in tidal volume during respiratory challenge even the reduction was restored at 2 months of age. Notably, the sigh-breathing pattern was changed in Cdkl5
-/y
mice, showing a transient reduction in sigh volume at 1-2 month of age and long-term attenuation of peak expiratory airflow from 1 to 3 month of age. Therefore, loss of
CDKL5
causes breathing deficiency, supporting a
CDKL5
-mediated regulation of respiratory function in mice.
...
PMID:Loss of CDKL5 disrupts respiratory function in mice. 2920 34